Some of the Best Interventional Radiology Doctors in Dallas at MTV IR Publish a New Blog Article Called “What is IR? – a FAQ for Doctors”

October 31, 2016. Dallas, TX. Majid and Van Meter Interventional Radiologists announce the publication of a new article that is aimed more at their fellow physicians than at patients and the general public. In it, they present a FAQ (Frequently Asked Question) approach to explain a little of what interventional radiology (IR) is, and how…

Details
Leg Pain Doctors in Dallas: Superficial Thrombophlebitis

Some of the Best Interventional Radiology Doctors in Dallas at MTV IR Publish a New Blog Article Called “What is IR? – a FAQ for Doctors”

October 24, 2016. Dallas, TX. Majid and Van Meter Interventional Radiologists announce the publication of a new article that is aimed more at their fellow physicians than at patients and the general public. In it, they present a FAQ (Frequently Asked Question) approach to explain a little of what interventional radiology (IR) is, and how…

Details

Sirtex Microspheres to Be Studied for Cholangiocarcinoma in SIRCCA and Included in ESMO Guidelines

October 11, 2016—Sirtex Medical Ltd announced the commencement of SIRCCA (Selective Internal Radiation Therapy [SIRT] in Cholangiocarcinoma), a phase 2 study of the company’s SIR-Spheres yttrium-90 (Y-90) resin microspheres in patients with unresectable intrahepatic cholangiocarcinoma (iCCA). According to Sirtex, SIRCCA is a prospective multicenter randomized controlled clinical study evaluating SIRT with the company’s microspheres before cisplatin-gemcitabine (CIS-GEM) chemotherapy…

Details

RESIRT Data on Sirtex’s SIR-Spheres to Treat Renal Cell Carcinoma Presented at ESMO Congress

October 10, 2016—Sirtex Medical Inc. announced that the initial safety and efficacy results from the RESIRT pilot clinical study were presented in a poster session at the 2016 European Society for Medical Oncology (ESMO) Congress held October 7–11 in Copenhagen, Denmark. The Australian-based RESIRT study is a single-arm, dose-escalation study of the company’s SIR-Spheres yttrium-90…

Details